A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.
The DME Facility Focus survey revealed best practices for coping with the challenges of aging facilities and implementing facility modernization.
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.
The authors discuss regulatory and patent issues with combination products.
The authors discuss regulatory and patent issues with combination products.
The authors discuss regulatory and patent issues with combination products.
The authors discuss regulatory and patent issues with combination products.
It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.
Ensuring reliable analytical methods and bioassays requires a well-thought-out strategy for evaluating method validity and systems suitability.
Having an effective and granular data management process in place will enable companies to meet the requirements of IDMP as well as help usher in a new age of digital-based identification, in which organizations can easily share data across borders.
Informatics platforms and automation solutions may support efforts to improve data integrity practices.
This study investigated the stability of solid lactose stored under high temperature and humidity conditions.
This study investigated the stability of solid lactose stored under high temperature and humidity conditions.
This study investigated the stability of solid lactose stored under high temperature and humidity conditions.
This study investigated the stability of solid lactose stored under high temperature and humidity conditions.
Research suggests that on-site audits are becoming less meaningful because suppliers are less willing to devote time to them.
The authors discuss the challenges of capsule filling in preclinical and clinical studies.
The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.